A Rare non-auto immunodeficiency disease (AIDS) related neo-plasm Kaposi sarcoma in Iraqi man: a case report
-
2015-03-20 https://doi.org/10.14419/ijm.v3i1.4390
-
Abstract
The aim of this article is to report unusual case of KS presenting in the patient with negative serology for AIDS. Kaposi Sarcoma (KS) is a rare entity. It is a vascular neoplasm mainly affecting the skin of the lower extremities. Although it is the most common neoplasm affecting patients with AIDS, sporadic cases in HIV-negative people have been reported but it is rare. Here, we present a case of a non-auto immunodeficiency disease (AIDS) related KS. A 72 year-old male, Iraqi patient presented to our oncology outpatient’s unit in Al-Shafaa Oncology Center with multiple subcutaneous nodules. The diagnosis was based on histopathological and immunohistochemical analysis of the excised lesion, serology tests and imaging investigations. The patient had a 13-month history of a slowly progressing pigmented multiple lesions on the lower and upper extremities. The patient had visceromegaly as splenomegaly at the time of presentation. His serum was negative for the common types of viral infections including Human Immunodeficiency Virus (HIV) on routine serology. On general examination, the man look well, no pallor, no fever, no cachexia present and no jaundice. There are a multiple ill defined, irregular hyper-pigmented nodules to plaques were present on forearm, legs, feet and hands. The nodules and plaque was firm in consistency and was non-tender. The lesions were deep reddish to brownish in color. The size of the lesions were arranged from 0.5-1.5 cm. No scaling was evident. The patient was under treatment with chemotherapeutic regimen of Paclitaxel.Â
-
References
[1] Antman K & Chang Y (2000). Kaposi's sarcoma. N Engl J Med, 342, 1027-1038. http://dx.doi.org/10.1056/NEJM200004063421407.
[2] Beral V, Peterman TA, Berkelman RL & Jaffer HW (1990). Kaposi sarcoma among persons with AIDS: a sexually trans-mitted infection. Lancet, 335, 123-128. http://dx.doi.org/10.1016/0140-6736(90)90001-L.
[3] Brenner B, Rakowsky E, Katz A, Gutman H, Sulkes A & Schacter J (1999). Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol, 14, 1097–1102. http://dx.doi.org/10.3892/ijo.14.6.1097.
[4] Bisceglia M, Bosman C, Carlesimo OA, Innocenzi D & Quirke P (1991). Kaposi's sarcoma: a clinico-pathologic overview. Tumori, 77, 291–310.
[5] Dal Maso L, Polesel J, Ascoli V, Zambon P, Budroni M & Fer-retti S (2005). Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer, 92, 188-193. http://dx.doi.org/10.1038/sj.bjc.6602265.
[6] Dictor M, Rambech E, Way D, Witte M & Bendsoe N (1996). Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol, 148, 2009-2016.
[7] Fatahzadeh M (2012). Kaposi sarcoma: review and medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol, 113(1), 2-16.
[8] Freidman-Kien AE, Laubenstein LJ, Rubinstein P, Buimovici-Klein E, Marmoa M & Stahl R (1982). Disseminated Kaposi sarcoma in young homosexual men. Ann Intern Med, 96, 693-700. http://dx.doi.org/10.7326/0003-4819-96-6-693.
[9] Gilani JA, Khan AU, Shahid S, Khan IU & Khan SU (2009). Clinical Presentation of Non-HIV Kaposi Sarcoma. Journal of the College of Physicians and Surgeons Pakistan, 19(9), 586-588.
[10] Gill PS, Wernz J & Scaden DT (1996). Randomized phase trial of liposomal Daunoblastine versus Doxorubicin, Bleomysin and Vincristine in AIDS related Kaposi sarcoma. J Clin Oncol, 14, 2353.
[11] Miles SA, Mitsuyasu RI & Aboulafia DM (1997). Kaposi's sarcoma. In: De Vita V, Hellman S, Rosenberg SA, eds. Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven Publishers; p. 2445–2449.
[12] Mohanna S, Bravo F, Ferrufino JC, Sanchez J & Gotuzzo E (2007). Classic Kaposi's sarcoma presenting in the oral cavity of two HIV-negative Quechua patients. Med Oral Patol Oral Cir Bucal, 12, 365-368.
[13] Mohanna S, Maco V, Gown A, Morales D, Bravo F & Gotuzzo E (2006). Is classic Kaposi's sarcoma endemic in Peru: report of a case in an indigenous patient. Am J Trop Med Hyg, 75, 324-326.
[14] Sanjay NA, Anuprita AR & Subodhkumar DJ (2014). Classic Kaposi's sarcoma: a rare case with unusual presentation. Our Dermatol Online, 5(1), 68-70. http://dx.doi.org/10.7241/ourd.20141.18.
[15] Sanna P, Rosselli M, Mainetti C, Gilliet F, Sessa C, Bernier J & Cavalli F (2000). Classical (HIV-negative) cutaneous Kaposi's sarcoma: a case report and a short review of the literature. Schweiz Med Wochenschr, 130, 988–992.
[16] Shetty K (2005). Management of oral Kaposi's sarcoma lesions on HIV-positive patient using highly active antiretroviral thera-py: Case report and a review of the literature. Oral Oncol, 41, 226-229. http://dx.doi.org/10.1016/j.ooe.2005.06.006.
[17] Solivetti FM, Elia F, Latini A, Cota C, Cordiali-Fei P & Di Carlo A (2011). AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants. J Exp Clin Cancer Res, 30, 40. http://dx.doi.org/10.1186/1756-9966-30-40.
[18] Vitale F, Viviano E, Perna AM, Bonura F, Mazzola G, Ajello F & Romano N (2000). Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8). Epidemiol Infect, 125, 671-675. http://dx.doi.org/10.1017/S0950268800004726.
[19] Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suqqett FE, Aldam DM & Denton AS (1995). Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet, 346, 799-802. http://dx.doi.org/10.1016/S0140-6736(95)91619-9.
-
Downloads
-
How to Cite
Al-Helfi, H., Al-Saad, R., & Al-Shewered, A. (2015). A Rare non-auto immunodeficiency disease (AIDS) related neo-plasm Kaposi sarcoma in Iraqi man: a case report. International Journal of Medicine, 3(1), 29-32. https://doi.org/10.14419/ijm.v3i1.4390Received date: 2015-02-20
Accepted date: 2015-03-17
Published date: 2015-03-20